Serum neurofilament light chain predicts spinal cord atrophy in neuromyelitis optica spectrum disorder-Reference-Cited by-同舟云学术

Serum neurofilament light chain predicts spinal cord atrophy in neuromyelitis optica spectrum disorder

Published:2023-11 Issue: Volume:384 Page:578218
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Li Yulin,Liu Yanyan,Zhao Wenjin,An Xueting,Zhang Fenghe,Zhang Tian-Xiang,Liu Ye,Du Chen,Zeng Pei,Yuan Meng,Zhang Ningnannan,Zhang Chao

Funder

Tianjin Municipal Natural Science Foundation

Natural Science Foundation of Tianjin Municipal Science and Technology Commission

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference28 articles.

1. Quantitative magnetic resonance imaging analysis of early markers of upper cervical cord atrophy in multiple sclerosis and Neuromyelitis Optica Spectrum disorder;Adibi;Mult. Scler. Int.,2021

2. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis;Barro;Brain J. Neurol.,2018

3. Spinal cord atrophy in Neuromyelitis Optica Spectrum disorders is spatially related to cord lesions and disability;Cacciaguerra;Radiology.,2020

4. Brain volumes quantification from MRI in healthy controls: assessing correlation, agreement and robustness of a convolutional neural network-based software against FreeSurfer, CAT12 and FSL;Chaves;J. Neuroradiol. = J. Neuroradiol.,2021

5. Reference values for plasma neurofilament light chain (NfL) in healthy Chinese;Chen;Clin. Chem. Lab. Med.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis;Medicina;2024-06-26

2. Brain and spinal cord atrophy in NMOSD and MOGAD: Current evidence and future perspectives;Multiple Sclerosis and Related Disorders;2024-05